Top compounds associated with response to CCDC157


Feature Type Standardized
Nominal ANOVA
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.015 0.7
mRNA Epothilone B GDSC1000 pan-cancer AAC 0.015 0.7
mRNA AC55649 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA salermide CTRPv2 pan-cancer AAC -0.021 0.7
mRNA ML083 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.022 0.7
mRNA Sorafenib CCLE pan-cancer AAC -0.021 0.7
mRNA Nutlin-3 CCLE pan-cancer AAC -0.021 0.7
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.7
mRNA VX-680 GDSC1000 pan-cancer AAC -0.023 0.7
Download CSV